Novartis

Anthropic's Long-Term Benefit Trust appoints Vas Narasimhan to Board of Directors

Anthropic's Long-Term Benefit Trust has appointed Vas Narasimhan, CEO of Novartis and physician-scientist, to Anthropic's Board of Directors. The appointment means Trust-appointed directors now constitute a majority of the Board, reinforcing the governance structure designed to balance commercial interests with Anthropic's public benefit mission. Narasimhan brings experience overseeing regulatory approval of over 35 novel medicines and is expected to contribute perspective on deploying powerful technology safely at scale, particularly in healthcare and life sciences.